Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy

Autor:	Mahmut Ozsahin, Philippe Pasche, Daniela Dragusanu, Luc Bron, Berrin Pehlivan, René O. Mirimanoff, Abderrahim Zouhair, François Luthi, Oscar Matzinger, David Azria
Jazyk:	angličtina
Rok vydání:	2009
Předmět:	Adult Male medicine.medical_specialty Aged Aged 80 and over Blood Loss Surgical/mortality Female Head and Neck Neoplasms/blood Head and Neck Neoplasms/mortality Hemoglobins/analysis Humans Middle Aged Neoplasm Staging Otorhinolaryngologic Surgical Procedures Postoperative Care Radiotherapy Adjuvant/mortality Survival Analysis Treatment Outcome Blood Loss Surgical Postoperative radiotherapy Locally advanced Hemoglobin levels Hemoglobins Blood loss Surgical oncology medicine business.industry Head and neck cancer medicine.disease Surgery Oncology Quartile Head and Neck Neoplasms Radiotherapy Adjuvant Hemoglobin business
Zdroj:	Annals of Surgical Oncology, vol. 16, no. 5, pp. 1331-1336
Popis:	AIM: To assess the influence of hemoglobin (Hb) levels in locally advanced head and neck cancer (LAHNC) patients treated with surgery and postoperative radiotherapy (PORT). MATERIAL AND METHODS: Pre- and postoperative Hb levels were collected in 79 patients treated with surgery followed by accelerated PORT for LAHNC. Median follow-up was 52 months (range 12-95 months). RESULTS AND DISCUSSION: Four-year overall survival (OS) rate was 51%. Neither pre- nor postoperative Hb level (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04890c6bbfc9efb1d6b24ff054577a16 https://serval.unil.ch/notice/serval:BIB_9F24F250B93C Zobrazit plný text záznamu